Glaukos (GKOS) Reports Q1 Loss, Tops Revenue Estimates

Glaukos (GKOS) came out with a quarterly loss of $0.70 per share versus the Zacks Consensus Estimate of a loss of $0.58. This compares to loss of $0.59 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -20.69%. A quarter ago, it was expected that this glaucoma treatments developer would post a loss of $0.56 per share when it actually produced a loss of $0.63, delivering a surprise of -12.50%.Over the last four quarters, the comp ...